This is a story of how America has been rewarded for its unflinching support for Benjamin Netanyahu and his genocidal government.
This is an informative insightful clip that pretty much sums up the current relationship between Israel and the U.S. there is good reason Israeli intelligence is sharing information of an assassination plot with the U.S., they know it plays on Trump’s mind and it will result in him doing exactly what he’s doing right now by ramping up strikes on Iran.
As ever, Trump responds exactly as intended by Netanyahu.
My thanks to David Hearse, editor in chief of Middle East Eye for the clip.
🎥 TikTok - https://t.co/4N7NGRP9Vv
If you listen to this and say WTF? You and I are on the same page.
The level of disconnect from reality is absolutely off the charts.
🎥 TikTok - https://t.co/B5svwhpiiP
First drive on FSD 14.3.3 Down Under! 🇦🇺
I go through everything that's been fixed vs v13.2.9 and test third party charger parking and a Perth Airport drop-off.
Anthropic pays $750,000+ a year for engineers who know how to build LLMs from scratch.
Stanford just released the exact lecture that teaches it - 1 hour 44 minutes, free, straight from CS229.
Bookmark and watch it this weekend.
It'll teach you more about how ChatGPT & Claude actually work than most people at top AI companies learn in their entire careers.
Scientists in Japan have developed a groundbreaking treatment that could double the average lifespan of cats, extending it from around 15 years to nearly 30 years.
The key lies in a protein called AIM (Apoptosis Inhibitor of Macrophage), discovered by Dr. Toru Miyazaki. While cats naturally produce AIM, they lack the ability to activate it effectively. This deficiency leads to the gradual buildup of waste in the kidneys, the leading cause of death in domestic cats.
Dr. Miyazaki’s team created an injectable form of activated AIM that directly restores the kidneys’ natural cleaning function. In clinical trials, cats with advanced kidney disease showed dramatic improvement after treatment. The therapy works both as a preventive measure for healthy cats and as a treatment for those already ill.
If approved, the treatment could revolutionize feline healthcare. Commercial rollout is expected to begin in Japan as early as 2025, with wider availability projected for 2027.
The research has also sparked interest for its potential applications in human medicine, as the AIM protein plays a similar waste-clearing role across species.
Instead of watching an hour movie, watch this. In 14 minutes, an Anthropic engineer who wrote Building Effective Agents will teach you more about building agents right than most developers figure out on their own in months.
INSTEAD OF WATCHING NETFLIX TONIGHT.
Spend 2 hour with this.
Claude AI FULL COURSE that teaches you how to BUILD and AUTOMATE anything.
Watch it and Bookmark it now.
Instead of scrolling tonight…
Spend 3 hours on this instead.
This guy just dropped a full AGI masterclass on AI, automation, and where the world is heading next.
The people watching this now will be ahead of everyone tomorrow.
Watch it. Save it.
Consolidated supply chain reports indicate that Optimus V3 has successfully cleared its engineering verification and is entering small-scale trial production this May.
According to these filings, core suppliers are expected to receive their first mass-production orders in mid-July, paving the way for a large-scale production ramp in August.
This 'May trial, July order' roadmap was further validated during Q1 2026 earnings calls by industry leaders in harmonic reducers and dexterous hand components.
Notably, seven key Chinese partners—including Sanhua, Tuopu, and Leaderdrive—have already passed Tesla’s PPA certification.
With localization now exceeding 60%, Tesla is aggressively positioned to drive down unit costs.